Authors:
Draube, A
Pfister, R
Vocherodt, M
Schuster, S
Kube, D
Diehl, V
Tesch, H
Citation: A. Draube et al., Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement, ANN HEMATOL, 80(2), 2001, pp. 83-89
Authors:
Re, D
Benenson, E
Beyer, M
Gresch, O
Draube, A
Diehl, V
Wolf, J
Citation: D. Re et al., Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236, AM J HEMAT, 67(1), 2001, pp. 6-9
Authors:
Scheid, C
Reiser, M
Draube, A
Josting, A
Fuchs, M
Chemnitz, J
Winter, S
Schulz, A
Engert, A
Diehl, V
Sohngen, D
Citation: C. Scheid et al., Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF, J HEMATH ST, 9(4), 2000, pp. 411-413
Authors:
Benedek, D
Kiehl, M
Draube, A
Chemnitz, J
Diehl, V
Sohngen, D
Citation: D. Benedek et al., Atypical chronic myeloid leukaemia with trisomy 21 mosaicism as a sole chromosomal abnormality, LEUK LYMPH, 38(5-6), 2000, pp. 639
Authors:
Josting, A
Reiser, M
Wickramanayake, PD
Rueffer, U
Draube, A
Sohngen, D
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: A. Josting et al., Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (Dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue - A highly effective regimen for patients with refractory or relapsed indolent lymphoma, LEUK LYMPH, 37(1-2), 2000, pp. 115-123
Authors:
Josting, A
Reiser, M
Wickramanayake, PD
Rueffer, U
Draube, A
Sohngen, D
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: A. Josting et al., Dexa-BEAM: An effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma, LEUK LYMPH, 37(1-2), 2000, pp. 185-187
Authors:
Reiser, M
Draube, A
Scheid, C
Fuchs, M
Josting, A
Diehl, V
Sohngen, D
Citation: M. Reiser et al., High platelet contamination in progenitor cell concentrates results in significantly lower CD34+yield after immunoselection, TRANSFUSION, 40(2), 2000, pp. 178-181
Authors:
Scheid, C
Reiser, M
Draube, A
Fuchs, M
Josting, A
Diehl, V
Sohngen, D
Citation: C. Scheid et al., Platelet contamination and immunomagnetic cellular selection with the Isolex 300i cell-selection device - Reply, TRANSFUSION, 40(10), 2000, pp. 1279-1280
Authors:
Mucke, S
Draube, A
Polack, A
Pawlita, M
Massoudi, N
Staratschek-Jox, A
Bohlen, H
Bornkamm, G
Diehl, V
Wolf, J
Citation: S. Mucke et al., Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors, INT J CANC, 86(3), 2000, pp. 301-306
Authors:
Reiser, M
Josting, A
Wickramanayake, PD
Draube, A
Scheid, C
Tesch, H
Wolf, J
Diehl, V
Engert, A
Citation: M. Reiser et al., Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma, LEUK LYMPH, 33(3-4), 1999, pp. 305-312
Authors:
Reiser, M
Josting, A
Draube, A
Mapara, MY
Scheid, C
Chemnitz, J
Tesch, H
Wolf, J
Diehl, V
Sohngen, D
Engert, A
Citation: M. Reiser et al., Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamidemobilization, BONE MAR TR, 23(12), 1999, pp. 1223-1228
Authors:
Scheid, C
Draube, A
Reiser, M
Schulz, A
Chemnitz, J
Nelles, S
Fuchs, M
Winter, S
Wickramanayake, PD
Diehl, V
Sohngen, D
Citation: C. Scheid et al., Using at least 5x10(6)/kg CD34(+) cells for autologous stern cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation, BONE MAR TR, 23(11), 1999, pp. 1177-1181